{"product_id":"immotest-i","title":"ImmoTest-I™","description":"\u003cp\u003e\u003cstrong\u003eAdvanced Body Defense Mapping Test\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmoTest-I™\u003c\/strong\u003e is an advanced blood-based immune profiling test designed to assess immune activation, immune suppression, and immune readiness in cancer-related clinical planning.\u003c\/p\u003e\n\u003cp\u003eThe immune system plays an important role in cancer surveillance, treatment response, and overall patient resilience. However, not every patient has the same immune condition. Some patients may show strong immune activation, while others may show signs of immune suppression, immune exhaustion, chronic inflammation, or immune imbalance.\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ helps provide a clearer picture of the patient’s immune status, allowing doctors to better understand whether the immune system is ready, suppressed, or imbalanced before planning immune-related oncology support.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHAT IMMOTEST-I™ IS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is an immune profiling test that evaluates selected immune markers, cytokines, and immune-cell activity patterns from a blood sample.\u003c\/p\u003e\n\u003cp\u003eIt is designed to help medical professionals understand the patient’s immune condition, especially in cases where immune-based support or precision oncology planning may be considered.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmoTest-I™ helps map how the immune system is behaving.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt provides information about immune activation and immune suppression, which may help support professional decision-making.\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eHOW IMMOTEST-I™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ analyses the immune system from multiple angles.\u003c\/p\u003e\n\u003cp\u003eThe test may evaluate immune-related markers linked to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eB-cell activity\u003c\/li\u003e\n\u003cli\u003eT-cell activity\u003c\/li\u003e\n\u003cli\u003ecytotoxic immune response\u003c\/li\u003e\n\u003cli\u003ehelper immune response\u003c\/li\u003e\n\u003cli\u003eimmune suppression\u003c\/li\u003e\n\u003cli\u003eregulatory immune pathways\u003c\/li\u003e\n\u003cli\u003eantigen-presenting cell activity\u003c\/li\u003e\n\u003cli\u003einflammatory and anti-inflammatory signalling\u003c\/li\u003e\n\u003cli\u003eimmune readiness\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBased on the sample report, the laboratory process includes serum isolation from whole blood, ELISA testing for immune activation\/suppression cytokines, and flow cytometry for selected immune-cell markers.\u003c\/p\u003e\n\u003cp\u003eBy reviewing these markers together, ImmoTest-I™ provides a structured immune profile that may help doctors assess whether the patient’s immune system is activated, suppressed, or imbalanced.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES IMMOTEST-I™ DIFFERENT?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune-Readiness Focused\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eImmoTest-I™ helps assess whether the patient’s immune system may be suitable for immune-related oncology support planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eActivation and Suppression Profiling\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt reviews both immune activation and immune suppression, instead of only giving a general “immune strength” impression.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe result may help doctors decide whether immune-related support is appropriate, needs to be delayed, or requires further evaluation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful Before Immune-Based Support\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eImmoTest-I™ may be useful before considering approaches that depend on immune recognition, immune response, or immune readiness.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProfessional Decision-Support Tool\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eIt is designed to support medical interpretation and clinical planning, not to replace specialist consultation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaps Immune Status\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eProvides a structured overview of immune activation, suppression, and immune balance.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Suitability Assessment\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps doctors assess whether immune-related support may be suitable for the patient.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Deeper Case Understanding\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eGives additional insight into the patient’s immune condition beyond routine blood tests.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalized Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps align the support strategy with the patient’s actual immune profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHelps Identify Immune Suppression\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay help detect patterns of immune down-regulation or immune imbalance that require professional attention.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful for Ongoing Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay support immune-status review during cancer management, follow-up, or advanced oncology planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eWHO \u003cmeta charset=\"utf-8\"\u003eIMMOTEST-I™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is designed for patients who require deeper immune assessment as part of professional oncology planning.\u003c\/p\u003e\n\u003cp\u003eIt may be considered for patients who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave a confirmed cancer diagnosis\u003c\/li\u003e\n\u003cli\u003eare being considered for immune-related support\u003c\/li\u003e\n\u003cli\u003erequire immune-readiness assessment\u003c\/li\u003e\n\u003cli\u003ehave complex cancer cases\u003c\/li\u003e\n\u003cli\u003eare undergoing advanced oncology planning\u003c\/li\u003e\n\u003cli\u003eneed immune activation or suppression profiling\u003c\/li\u003e\n\u003cli\u003erequire better understanding of immune status\u003c\/li\u003e\n\u003cli\u003emay be considered for tumour-recognition or immune-support strategies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSuitability and interpretation should always be guided by qualified healthcare professionals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHEN IMMOTEST-I™ MAY BE RECOMMENDED?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ may be considered before:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eimmune-related oncology support\u003c\/li\u003e\n\u003cli\u003epersonalised cancer support planning\u003c\/li\u003e\n\u003cli\u003etumour-recognition support strategies\u003c\/li\u003e\n\u003cli\u003eadvanced oncology monitoring\u003c\/li\u003e\n\u003cli\u003ecombination support programs\u003c\/li\u003e\n\u003cli\u003edoctor-led cancer management review\u003c\/li\u003e\n\u003cli\u003eimmune-readiness evaluation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt may also be used when doctors need a clearer understanding of whether the patient’s immune system is activated, suppressed, or imbalanced.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT THE RESULT MAY SHOW?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ may provide information related to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eimmune activation\u003c\/li\u003e\n\u003cli\u003eimmune suppression\u003c\/li\u003e\n\u003cli\u003ecytokine activity\u003c\/li\u003e\n\u003cli\u003eT-cell activity\u003c\/li\u003e\n\u003cli\u003eB-cell activity\u003c\/li\u003e\n\u003cli\u003ecytotoxic immune response\u003c\/li\u003e\n\u003cli\u003ehelper immune response\u003c\/li\u003e\n\u003cli\u003eregulatory immune activity\u003c\/li\u003e\n\u003cli\u003eantigen-presenting cell function\u003c\/li\u003e\n\u003cli\u003eimmune balance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe sample report includes markers such as CD19, CD20, CD28, CD62L, IFN-γ, IL-4, IL-6, IL-2, TNF-α, CD25, CTLA4, CD80, and CD86. These are immune-related markers used to support immune activation\/suppression profiling.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHOW RESULTS SHOULD BE USED?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ results should be interpreted by qualified medical professionals.\u003c\/p\u003e\n\u003cp\u003eThe result should be reviewed together with:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ecancer diagnosis\u003c\/li\u003e\n\u003cli\u003eimaging reports\u003c\/li\u003e\n\u003cli\u003eblood investigations\u003c\/li\u003e\n\u003cli\u003etreatment history\u003c\/li\u003e\n\u003cli\u003ecurrent medications\u003c\/li\u003e\n\u003cli\u003eimmune-related conditions\u003c\/li\u003e\n\u003cli\u003eperformance status\u003c\/li\u003e\n\u003cli\u003esymptoms\u003c\/li\u003e\n\u003cli\u003eoverall patient condition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe test does not provide a treatment decision by itself. It supports better clinical understanding and professional case planning.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is an immune profiling test. It is not intended to diagnose cancer, treat cancer, cure cancer, or prevent cancer.\u003c\/p\u003e\n\u003cp\u003eResults must be interpreted by qualified medical professionals and reviewed together with the patient’s clinical history, imaging, laboratory findings, treatment status, and overall medical condition.\u003c\/p\u003e\n\u003cp\u003eImmoTest-I™ is designed to support immune-status assessment and personalized oncology planning, not to replace oncology consultation or standard medical care.\u003c\/p\u003e","brand":"Cell Tissue","offers":[{"title":"Default Title","offer_id":44191475269668,"sku":"CTTIMO10076","price":5999.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/CellTissueUKMImmoTest-I01.jpg?v=1779183366","url":"https:\/\/shop.cytolifeasia.com\/products\/immotest-i","provider":"CytoLife","version":"1.0","type":"link"}